Journal Title
PHYTOTHERAPY RESEARCH

PHYTOTHER RES

ISSN / eISSN
0951-418X / 1099-1573
Aims and Scope
Phytotherapy Research is a monthly, international journal for the publication of original research papers, short communications, reviews and letters on medicinal plant research. Key areas of interest are pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to full clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Papers concerned with the effects of common food ingredients and standardised plant extracts, including commercial products, are particularly welcome, as are mechanistic studies on isolated natural products.

Short communications dealing with the pharmacology and screening of crude or uncharacterised extracts will be considered for publication only if they are clearly of interest to our international readership and are not deemed more suitable for a regional audience.

Phytotherapy Research does not publish agricultural, phytochemical, structure elucidation, quality control or botanical identification papers unless directly pertinent to the pharmacological effects or overall safety of plant based medicines currently in use.
Subject Area

CHEMISTRY, MEDICINAL

PHARMACOLOGY & PHARMACY

CiteScore
11.80 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q1 #24/301
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
CHEMISTRY, MEDICINAL - SCIE Q1
PHARMACOLOGY & PHARMACY - SCIE Q1
H-index
112
Country/Area of Publication
ENGLAND
Publisher
John Wiley and Sons Ltd
Publication Frequency
Monthly
Year Publication Started
1987
Annual Article Volume
323
Open Access
NO
Contact
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Submission in mid-June, revision in late July, it is a minor revision. After revision, it will be accepted in August. It requires a high level of language proficiency and the basic need for a professional native speaker to proofread, even if we have already written it carefully. This journal has a good reputation in the field of traditional Chinese medicine and is basically on par with Phytomedicine, which has just been upgraded to the first category of the Chinese Academy of Sciences. Its impact factor is higher than that of the Journal of Ethnopharmacology, but the latter is a well-established and reputable publication. One year, Yangtze University even listed it as a low-risk journal, which is quite absurd. It must be said that this CJDX is quite impressive, not only in terms of reputation but also in terms of its influence.
2023-02-27
Submitted: April 25, 2023
Final revisions submitted: July 20, 2023
Accepted: August 6, 2023
The first round of revisions came back on May 31st with feedback from 7 reviewers and about 30 modifications suggested by the editor, which can be considered as 8 reviewers.
The second round of revisions was on July 15th, with 5 reviewers raising around 10 additional questions. The revisions were sent back on July 20th and accepted on August 6th.
On August 9th, an email was sent to confirm the license agreement and the article entered the production stage, receiving a DOI number.
2023-08-09

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now